PROVIDER PROFILE · NPI 1508920398

Ted StampienM.D.

DermatologyScranton, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,743

Unique beneficiaries

—

Total services

4,296

Distinct HCPCS

Medicare payment

$166K

Peer benchmark

Total Medicare services vs. 531 Dermatology providers in PA — top quintile (cohort median 2,070).

PRESCRIBING · PART D · 2024

Total Rx claims

1,005

Beneficiaries

—

Total drug cost

$27K

Distinct drugs

Brand share

9.9%

Top prescribed drugs

Triamcinolone Acetonide197 claims

Metronidazole146 claims

Fluocinonide136 claims

Doxycycline Hyclate70 claims

Betamethasone Dipropionate64 claims

QUALITY · MIPS · 2024

Final MIPS score

89.1

Quality

96.4

Cost

67.3

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.59%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$221

Payment records

By payment type

Food and Beverage$221

REFERRAL NETWORK

Where Ted Stampien's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Northeast Dermatopathology Institute Clinical Laboratory · Clarks Summit, PA	230	306
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	78	120
COMMUNITY MEDICAL CENTER	27	34
WILKES BARRE HOSPITAL COMPANY LLC	17	21
Jamie Stallman Diagnostic Radiology · Scranton, PA	11	17

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history